Mon. May 25th, 2026
Spread the love

Tiana Mangakahia, who was known for her precise passing and incredible playmaking abilities while starring for Syracuse’s women’s basketball team, died on Thursday at the age of 30 after a lengthy battle with cancer.

Her death was announced in a post on her Instagram account and also confirmed by Syracuse athletics. The post on her Instagram said: “Tiana was a shining light who touched the lives of everyone she met with her kindness, strength, and warmth. She fought right till the very end, showing courage and grace beyond words.”

In a post dated Sept. 3, Mangakahia announced that her health had “taken a negative turn” and her cancer had “progressed” causing her to experience “significant physical decline.”

Mangakahia’s public battle with cancer began when she was a junior at Syracuse. A native of Queensland, Australia, she came to the U.S. to play first at Hutchinson Community College in Kansas, and then transferred to upstate New York to join the Orange, then coached by Quentin Hillsman. She quickly established herself as an electric point guard with a high basketball IQ and superb court vision. As a sophomore, she led the nation in assists with 9.8 per game. Since 2009, the only college player to average more assists in a single season was Courtney Vandersloot in 2011.

In her first two seasons at Syracuse, Mangakahia also led the NCAA in assist rate, posting marks of 60.4 and 51.7. Since 2009, there have only been four seasons recorded by players (who have played in at least 20 games and at least 20 minutes per game) with assist rates higher than 50 percent. Mangakahia owns two of them, Caitlin Clark has one, and the fourth belongs to Dequesha McClanahan of Winthrop, according to Her Hoop Stats.

During both of those seasons, Mangakahia helped lead the Orange to the NCAA Tournament.

Then her first cancer diagnosis surfaced. In November 2019, she underwent a double mastectomy while battling stage 2 grade 3 invasive ductal carcinoma — a form of breast cancer — which caused her to miss the 2019-20 season.

Mangakahia courageously returned to the court the following season though, averaging 11.5 points and 7.2 assists per game, again guiding the Orange into March Madness. And once again, she was second nationally in assists per game.

“If anyone has 600-plus days off, and comes back and leads the country in assists, that’s an amazing accomplishment. I don’t even know what to say (about that),” Hillsman said back in February 2021, shortly after Mangakahia announced she wouldn’t use her extra year of collegiate eligibility and would turn pro instead. “Tiana has been what she’s always been: very steady, trying to lead our team by example and playing the hardest she can play.”

Mangakahia left Syracuse as the owner of several program and ACC records. She is the ACC’s all-time leader in career assists per game (8.7), assist percentage (52.8) and free throw percentage (87.3). She’s Syracuse’s all-time leader in total assists with 736, which is fourth-best in ACC history. A two-time All-ACC First Team selection, a two-time WBCA All-American and a two-time Lieberman Award finalist, she also holds single-game Syracuse records in assists (17) and free throws made (20). Mangakahia is also the owner of the ACC Tournament single game assists record with 13 vs. Miami in 2019.

In the NCAA record books, Mangakahia’s career assist average is fifth-best all-time and the best of any collegiate player this century — just .44 percentage points better than what Vandersloot posted at Gonzaga.

She went unselected in the 2021 WNBA Draft, but joined the Phoenix Mercury briefly for training camp before being waived. Mangakahia then embarked on an international pro career with stops in Russia, France and her native Australia. In 2022, she was named to the All-Star Five and MVP of the North in NBL1. Mangakahia also featured for the Australian national team in the 2021 FIBA Asia Cup, helping the Opals win a bronze medal.

Mangakahia had announced her retirement in 2023 after her breast cancer had progressed to stage 4, but she returned to the court earlier this year in NBL1 and averaged 12.1 points and 3.6 assists per game. She had intended to play in the upcoming season too, signing with the New Zealand-based Tokomanawa Queens.

“Tiana defined courage, inspiration, and passion,” Syracuse athletic director John Wildhack said in a statement. “An All-American on the basketball court, she was an even better person off the court. She was kind, considerate, caring, and always uplifting even during the most challenging of times.”

Current Syracuse coach Felisha Legette-Jack called Mangakahia the “ultimate fighter.”

Many others around the world of women’s basketball offered comments too. Indiana Fever star Sophie Cunningham — who crossed paths with Mangakahia in Phoenix’s 2021 training camp — said she was “always so sweet with the brightest smile.” North Carolina coach Courtney Banghart wrote that Mangakahia was, “A great competitor, a true leader, and always a class act.”

Rhode Island coach Tammi Reiss, who was a Syracuse assistant during Mangakahia’s first two seasons, said she could “play that (point guard) position like no other.”

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.